The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.
The identification of a highly selective D(2) partial agonist, D(3) antagonist tool molecule which demonstrates high levels of brain exposure and selectivity against an extensive range of dopamine, serotonin, adrenergic, histamine, and muscarinic receptors is described.